Fred Hutchinson Cancer Research Center: Gary Gilliland
Gary Gilliland plans to step down as president and director of the Fred Hutchinson Cancer Research Center in Seattle in 2020. Prior to working at the Hutch, Gilliland served as director of the leukemia program at Dana-Farber/Harvard Cancer, senior VP and global oncology franchise head at Merck, and vice dean and VP of precision medicine at the Perelman School of Medicine at the University of Pennsylvania.
Sophia Genetics: Gaëtan Fraikin, Sergei Yakneen
Sophia Genetics has hired Gaëtan Fraikin as chief marketing officer and Sergei Yakneen as chief information officer. Fraikin joins the Swiss company after short stints with Addictive, Roche, and Illumina, plus 14 years as a marketing agency executive. Yakneen is a former technical officer with the European Molecular Biology Laboratory and led the technical working group of the Pan Cancer Analysis of Whole Genomes project for the Ontario Institute for Cancer Research.
Ontera: Mark Rose and Raparti Swayambhu
Nanopore diagnostics firm Ontera has appointed Mark Rose as VP of product management and Raparti Swayambhu as VP of software.
Rose will be responsible for development, launch, and commercial activities of the firm's diagnostic product portfolio. He comes from Google, where he was a product lead and helped launch the Nest brand of internet-connected devices for the home. He has also worked at Motorola and Facebook. He holds an MBA from the Craig School of Business at California State University, Fresno.
Swayambhu will oversee the firm's software development, enterprise IT, and data science teams. He brings more than 20 years of experience in software development and has held technical leadership roles at Sema4 and Genentech, among other firms. He holds a master's degree in computer science from Carnegie Mellon University.
For additional recent executive appointments and promotions in the omics and molecular diagnostics industries, please see the People in the News page on our website.